NO984143L - Ny prosess for å fremstille overflatemodifiserende stoffer - Google Patents

Ny prosess for å fremstille overflatemodifiserende stoffer

Info

Publication number
NO984143L
NO984143L NO984143A NO984143A NO984143L NO 984143 L NO984143 L NO 984143L NO 984143 A NO984143 A NO 984143A NO 984143 A NO984143 A NO 984143A NO 984143 L NO984143 L NO 984143L
Authority
NO
Norway
Prior art keywords
new process
surface modifying
producing surface
modifying substances
heparin
Prior art date
Application number
NO984143A
Other languages
English (en)
Norwegian (no)
Other versions
NO984143D0 (no
Inventor
Elisabeth Scholander
Original Assignee
Norsk Hydro As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norsk Hydro As filed Critical Norsk Hydro As
Priority to NO984143A priority Critical patent/NO984143L/no
Publication of NO984143D0 publication Critical patent/NO984143D0/no
Priority to JP2000568523A priority patent/JP4152075B2/ja
Priority to DK99944936T priority patent/DK1112097T3/da
Priority to CA002342991A priority patent/CA2342991C/en
Priority to ES99944936T priority patent/ES2203177T3/es
Priority to KR1020017002986A priority patent/KR100669132B1/ko
Priority to PT99944936T priority patent/PT1112097E/pt
Priority to DE69909104T priority patent/DE69909104T2/de
Priority to BRPI9913516-7A priority patent/BR9913516B1/pt
Priority to PCT/NO1999/000277 priority patent/WO2000013718A1/en
Priority to AT99944936T priority patent/ATE243538T1/de
Priority to US09/763,873 priority patent/US6461665B1/en
Priority to AU57652/99A priority patent/AU757913B2/en
Priority to EP99944936A priority patent/EP1112097B1/en
Publication of NO984143L publication Critical patent/NO984143L/no
Priority to NO20011182A priority patent/NO321029B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0005—Use of materials characterised by their function or physical properties
    • A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
    • A61L33/0029—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate using an intermediate layer of polymer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Materials Engineering (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Steroid Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO984143A 1998-09-09 1998-09-09 Ny prosess for å fremstille overflatemodifiserende stoffer NO984143L (no)

Priority Applications (15)

Application Number Priority Date Filing Date Title
NO984143A NO984143L (no) 1998-09-09 1998-09-09 Ny prosess for å fremstille overflatemodifiserende stoffer
EP99944936A EP1112097B1 (en) 1998-09-09 1999-09-08 New process for preparing surface modification substances
PT99944936T PT1112097E (pt) 1998-09-09 1999-09-08 Processo novo para preparar substancias de modificacao de superficies
BRPI9913516-7A BR9913516B1 (pt) 1998-09-09 1999-09-08 processo para a produção de uma modificação em superfìcie que tem uma atividade não trombogênica melhorada.
CA002342991A CA2342991C (en) 1998-09-09 1999-09-08 Antithrombogenic surfaces comprising immobilized heparin and methods for producing same
ES99944936T ES2203177T3 (es) 1998-09-09 1999-09-08 Nuevo procedimiento para preparar sustancias de modificacion de superficies.
KR1020017002986A KR100669132B1 (ko) 1998-09-09 1999-09-08 표면 개질을 생성하는 신규 방법
JP2000568523A JP4152075B2 (ja) 1998-09-09 1999-09-08 表面改質物質を調整する新方法
DE69909104T DE69909104T2 (de) 1998-09-09 1999-09-08 Neues verfahren zur herstellung von mitteln zur oberflächenbehandlung
DK99944936T DK1112097T3 (da) 1998-09-09 1999-09-08 Ny fremgangsmåde til fremstilling af substanser til overflademodificering
PCT/NO1999/000277 WO2000013718A1 (en) 1998-09-09 1999-09-08 New process for preparing surface modification substances
AT99944936T ATE243538T1 (de) 1998-09-09 1999-09-08 Neues verfahren zur herstellung von mitteln zur oberflächenbehandlung
US09/763,873 US6461665B1 (en) 1998-09-09 1999-09-08 Process for preparing surface modification substances
AU57652/99A AU757913B2 (en) 1998-09-09 1999-09-08 New process for preparing surface modification substances
NO20011182A NO321029B1 (no) 1998-09-09 2001-03-08 Ny fremgangsmate for a fremskaffe overflatemodifikasjon samt overflatemodifisert substrat.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO984143A NO984143L (no) 1998-09-09 1998-09-09 Ny prosess for å fremstille overflatemodifiserende stoffer

Publications (2)

Publication Number Publication Date
NO984143D0 NO984143D0 (no) 1998-09-09
NO984143L true NO984143L (no) 2000-03-10

Family

ID=19902393

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984143A NO984143L (no) 1998-09-09 1998-09-09 Ny prosess for å fremstille overflatemodifiserende stoffer

Country Status (14)

Country Link
US (1) US6461665B1 (es)
EP (1) EP1112097B1 (es)
JP (1) JP4152075B2 (es)
KR (1) KR100669132B1 (es)
AT (1) ATE243538T1 (es)
AU (1) AU757913B2 (es)
BR (1) BR9913516B1 (es)
CA (1) CA2342991C (es)
DE (1) DE69909104T2 (es)
DK (1) DK1112097T3 (es)
ES (1) ES2203177T3 (es)
NO (1) NO984143L (es)
PT (1) PT1112097E (es)
WO (1) WO2000013718A1 (es)

Families Citing this family (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6254564B1 (en) 1998-09-10 2001-07-03 Percardia, Inc. Left ventricular conduit with blood vessel graft
SE515295C2 (sv) 1999-11-23 2001-07-09 Medicarb Ab Förfarande för framställning av konjugat av en biologiskt aktiv polysackarid och ett fast substrat, samt sådana konjugat
US20030229374A1 (en) * 2002-05-10 2003-12-11 Salviac Limited Embolic protection system
US6926965B2 (en) * 2002-09-11 2005-08-09 Novartis Ag LbL-coated medical device and method for making the same
US8071569B2 (en) * 2002-09-20 2011-12-06 Mousa Shaker A Oxidized heparin fractions and their use in inhibiting angiogenesis
US20050281857A1 (en) * 2004-05-25 2005-12-22 Heyer Toni M Methods and reagents for preparing biomolecule-containing coatings
US20060159650A1 (en) * 2005-01-14 2006-07-20 Bacterin, Inc. Composition and method for covalently coupling an antithrombotic substance and a hydrophilic polymer
DE102005003632A1 (de) 2005-01-20 2006-08-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Katheter für die transvaskuläre Implantation von Herzklappenprothesen
CA2630823C (en) 2005-12-13 2015-02-10 Exthera Ab Method for extracorporeal removal of a pathogenic microbe, an inflammatory cell or an inflammatory protein from blood
US8986713B2 (en) * 2006-05-12 2015-03-24 W. L. Gore & Associates, Inc. Medical device capable of being compacted and expanded having anti-thrombin III binding activity
US8021677B2 (en) 2006-05-12 2011-09-20 Gore Enterprise Holdings, Inc. Immobilized biologically active entities having a high degree of biological activity
US8496953B2 (en) * 2006-05-12 2013-07-30 W. L. Gore & Associates, Inc. Immobilized biologically active entities having a high degree of biological activity following sterilization
US9114194B2 (en) * 2006-05-12 2015-08-25 W. L. Gore & Associates, Inc. Immobilized biologically active entities having high biological activity following mechanical manipulation
CA2664299C (en) 2006-09-15 2016-01-19 Toray Industries, Inc. Substrate comprising an anticoagulant and a hydrophilic polymer and manufacturing method thereof
US20080200421A1 (en) 2007-02-21 2008-08-21 Zhao Jonathon Z Coating for a medical device having an anti-thrombotic conjugate
US20090281059A1 (en) 2007-02-21 2009-11-12 Robert Falotico Coating for a medical device having an anti-thrombotic conjugate
US9693841B2 (en) 2007-04-02 2017-07-04 Ension, Inc. Surface treated staples, sutures and dental floss and methods of manufacturing the same
US8114465B2 (en) * 2007-04-02 2012-02-14 Ension, Inc. Process for preparing a substrate coated with a biomolecule
US7896915B2 (en) 2007-04-13 2011-03-01 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
US8383156B2 (en) 2007-04-30 2013-02-26 Cordis Corporation Coating for a medical device having an anti-thrombotic conjugate
US8663148B2 (en) * 2007-06-18 2014-03-04 Exthera Medical Corporation Device and method for restoration of the condition of blood
WO2008155683A1 (en) 2007-06-18 2008-12-24 Firmenich Sa Malodor counteracting compositions and method for their use
US20090018646A1 (en) 2007-07-10 2009-01-15 Zhao Jonathon Z Coating Employing an Anti-Thrombotic Conjugate
US20090192079A1 (en) * 2007-10-09 2009-07-30 Genzyme Corporation Prolonged delivery of heparin-binding growth factors from heparin-derivatized collagen
ES2903231T3 (es) 2008-02-26 2022-03-31 Jenavalve Tech Inc Stent para el posicionamiento y anclaje de una prótesis valvular en un sitio de implantación en el corazón de un paciente
US9044318B2 (en) 2008-02-26 2015-06-02 Jenavalve Technology Gmbh Stent for the positioning and anchoring of a valvular prosthesis
GB0816783D0 (en) * 2008-09-15 2008-10-22 Carmeda Ab Immobilised biological entities
US7819914B2 (en) 2008-12-16 2010-10-26 Cordis Corporation Adhesion promoting primer for coated surfaces
US20100161039A1 (en) * 2008-12-23 2010-06-24 Vipul Dave Adhesion promoting temporary mask for coated surfaces
AU2010200316A1 (en) * 2009-01-30 2010-08-19 Cordis Corporation Reservoir Eluting Stent
AU2010215936B2 (en) 2009-02-21 2015-03-05 Covidien Lp Medical devices having activated surfaces
EP2398525B1 (en) * 2009-02-21 2012-12-05 Sofradim Production Medical device with degradation-retarding coating
US8658707B2 (en) 2009-03-24 2014-02-25 W. L. Gore & Associates, Inc. Expandable functional TFE copolymer fine powder, the expanded functional products obtained therefrom and reaction of the expanded products
US9139669B2 (en) * 2009-03-24 2015-09-22 W. L. Gore & Associates, Inc. Expandable functional TFE copolymer fine powder, the expandable functional products obtained therefrom and reaction of the expanded products
US8591932B2 (en) * 2009-09-17 2013-11-26 W. L. Gore & Associates, Inc. Heparin entities and methods of use
US8758286B2 (en) 2009-12-01 2014-06-24 Exthera Medical Corporation Method for removing cytokines from blood with surface immobilized polysaccharides
RU2539566C2 (ru) 2009-12-24 2015-01-20 Торэй Индастриз, Инк. Гидрофильное полимерное соединение, имеющее антикоагулянтный эффект
GB201004101D0 (en) * 2010-03-12 2010-04-28 Carmeda Ab Immobilised biological entities
JP2013526388A (ja) 2010-05-25 2013-06-24 イエナバルブ テクノロジー インク 人工心臓弁、及び人工心臓弁とステントを備える経カテーテル搬送体内プロテーゼ
US9839540B2 (en) 2011-01-14 2017-12-12 W. L. Gore & Associates, Inc. Stent
US10166128B2 (en) 2011-01-14 2019-01-01 W. L. Gore & Associates. Inc. Lattice
WO2012112724A1 (en) 2011-02-15 2012-08-23 Exthera Medical, Llc Device and method for removal of blood-borne pathogens, toxins and inflammatory cytokines
US9415193B2 (en) 2011-03-04 2016-08-16 W. L. Gore & Associates, Inc. Eluting medical devices
US20120310210A1 (en) 2011-03-04 2012-12-06 Campbell Carey V Eluting medical devices
CN105664252B (zh) 2011-03-11 2019-11-19 W.L.戈尔及同仁股份有限公司 固定的生物实体的改进
TW201309354A (zh) 2011-06-23 2013-03-01 Toray Industries 醫療材料
TW201311774A (zh) 2011-06-23 2013-03-16 Toray Industries 具有抗血液凝固作用的疏水性高分子化合物
US9775933B2 (en) 2012-03-02 2017-10-03 W. L. Gore & Associates, Inc. Biocompatible surfaces and devices incorporating such surfaces
DK2861273T3 (da) 2012-06-13 2017-11-27 Exthera Medical Corp Anvendelse af heparin og kulhydrater til behandling af cancer.
US9283072B2 (en) 2012-07-25 2016-03-15 W. L. Gore & Associates, Inc. Everting transcatheter valve and methods
US10376360B2 (en) 2012-07-27 2019-08-13 W. L. Gore & Associates, Inc. Multi-frame prosthetic valve apparatus and methods
US9931193B2 (en) 2012-11-13 2018-04-03 W. L. Gore & Associates, Inc. Elastic stent graft
US9101469B2 (en) 2012-12-19 2015-08-11 W. L. Gore & Associates, Inc. Prosthetic heart valve with leaflet shelving
US9968443B2 (en) 2012-12-19 2018-05-15 W. L. Gore & Associates, Inc. Vertical coaptation zone in a planar portion of prosthetic heart valve leaflet
US9144492B2 (en) 2012-12-19 2015-09-29 W. L. Gore & Associates, Inc. Truncated leaflet for prosthetic heart valves, preformed valve
WO2014209782A1 (en) 2013-06-24 2014-12-31 Exthera Medical Corporation Blood filtration system containing mannose coated substrate
CN105491978A (zh) 2013-08-30 2016-04-13 耶拿阀门科技股份有限公司 用于假体瓣膜的径向可折叠框架及其制造方法
CN105705177B (zh) 2013-11-08 2019-10-22 艾克塞拉医疗公司 使用吸附介质诊断感染性疾病的方法
US9795721B2 (en) 2013-11-28 2017-10-24 Toray Industries, Inc. Antithrombotic material
WO2015080176A1 (ja) 2013-11-28 2015-06-04 東レ株式会社 抗血栓性材料
US10842918B2 (en) 2013-12-05 2020-11-24 W.L. Gore & Associates, Inc. Length extensible implantable device and methods for making such devices
BR112016018452A2 (pt) 2014-02-12 2018-06-26 Toray Industries vaso sanguíneo artificial.
US11839698B2 (en) 2014-03-13 2023-12-12 W. L. Gore & Associates, Inc. Drug composition and coating
DE15782250T1 (de) 2014-04-24 2017-08-10 Exthera Medical Corporation Verfahren zur Entfernung von Bakterien aus Blut unter Verwendung einer hohen Durchflussrate
US9827094B2 (en) 2014-09-15 2017-11-28 W. L. Gore & Associates, Inc. Prosthetic heart valve with retention elements
CA2959975A1 (en) 2014-09-22 2016-03-31 Exthera Medical Corporation Wearable hemoperfusion device
WO2016177562A1 (en) 2015-05-01 2016-11-10 Jenavalve Technology, Inc. Device and method with reduced pacemaker rate in heart valve replacement
EP3095509A1 (en) 2015-05-18 2016-11-23 Defymed Membranes functionalized with heparin for bioartificial organs
US10561766B2 (en) 2015-09-15 2020-02-18 W. L. Gore & Associates, Inc. Drug composition and coating
WO2017151797A1 (en) 2016-03-02 2017-09-08 Exthera Medical Corporation Method for treating drug intoxication
US11911551B2 (en) 2016-03-02 2024-02-27 Exthera Medical Corporation Method for treating drug intoxication
WO2017184153A1 (en) 2016-04-21 2017-10-26 W. L. Gore & Associates, Inc. Diametrically adjustable endoprostheses and associated systems and methods
JP7081749B2 (ja) 2016-05-13 2022-06-07 イエナバルブ テクノロジー インク 心臓弁プロテーゼ送達システム
CN109790259B (zh) 2016-09-30 2021-12-07 东丽株式会社 共聚物和使用其的医疗材料
MX2019004004A (es) 2016-10-07 2019-06-10 Toray Industries Tela tejida tubular.
EP3318294A1 (en) 2016-11-08 2018-05-09 Defymed Kit for in situ delivery of a compound of interest
CN110392557A (zh) 2017-01-27 2019-10-29 耶拿阀门科技股份有限公司 心脏瓣膜模拟
BR112019016808A2 (pt) 2017-03-31 2020-04-07 Toray Industries estrutura cilíndrica
US10959842B2 (en) 2017-09-12 2021-03-30 W. L. Gore & Associates, Inc. Leaflet frame attachment for prosthetic valves
WO2019067219A1 (en) 2017-09-27 2019-04-04 W. L. Gore & Associates, Inc. PROSTHETIC VALVE WITH EXTENSIBLE FRAME AND ASSOCIATED SYSTEMS AND METHODS
CA3072781C (en) 2017-09-27 2022-07-05 W.L. Gore & Associates, Inc. Prosthetic valves with mechanically coupled leaflets
EP3694445B1 (en) 2017-10-13 2024-07-10 Edwards Lifesciences Corporation Telescoping prosthetic valve and delivery system
JP7052032B2 (ja) 2017-10-31 2022-04-11 ダブリュ．エル．ゴア アンド アソシエイツ，インコーポレイティド 組織内方成長を促進する医療用弁及び弁膜
KR20200112812A (ko) 2018-01-30 2020-10-05 도레이 카부시키가이샤 평직물, 그 제조 방법 및 스텐트 그래프트
WO2019170859A2 (en) 2018-03-09 2019-09-12 Carmeda Ab Improvements to immobilising biological entities
AU2019232163A1 (en) 2018-03-09 2020-09-03 Carmeda Ab Improvements to processes for immobilising biological entities
US12053381B2 (en) 2018-07-18 2024-08-06 W. L. Gore & Associates, Inc. Implantable medical device deployment system
AU2019354085A1 (en) 2018-10-03 2021-03-18 Carmeda Ab Immobilised biological entities
US20200179663A1 (en) 2018-12-11 2020-06-11 W. L. Gore & Associates, Inc. Medical devices for shunts, occluders, fenestrations and related systems and methods
CN113490452A (zh) 2018-12-21 2021-10-08 W.L.戈尔及同仁股份有限公司 可植入心脏传感器
US20220062513A1 (en) 2019-01-30 2022-03-03 Toray Industries, Inc. Medical base material for indwelling cardiovascular device
US11497601B2 (en) 2019-03-01 2022-11-15 W. L. Gore & Associates, Inc. Telescoping prosthetic valve with retention element
JP2022534191A (ja) 2019-05-16 2022-07-28 エクスセラ メディカル コーポレイション 内皮糖衣構造を調節するための方法
CN114727821A (zh) 2019-11-15 2022-07-08 W.L.戈尔及同仁股份有限公司 左心耳设备和方法
AU2021425045B2 (en) 2020-02-04 2024-05-23 W. L. Gore & Associates, Inc. Inflow / outflow cannula
EP3892259A1 (en) 2020-04-09 2021-10-13 Defymed Membranes for medical devices
US20230157588A1 (en) 2020-04-09 2023-05-25 Defymed Membranes for Medical Devices

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8200751L (sv) * 1982-02-09 1983-08-10 Olle Larm Forfarande for kovalent koppling for framstellning av konjugat och hervid erhallna produkter
US4600652A (en) * 1985-04-01 1986-07-15 Warner-Lambert Company Permanently bonded antithrombogenic polyurethane surface
US5049403A (en) * 1989-10-12 1991-09-17 Horsk Hydro A.S. Process for the preparation of surface modified solid substrates
IT1260136B (it) 1992-04-17 1996-03-28 Alfa Wassermann Spa Glicosaminoglicani semisintetici contenenti acido alfa-l-galatturonicosostituito con radicali nucleofili in posizione 3
US5679659A (en) 1995-08-22 1997-10-21 Medtronic, Inc. Method for making heparinized biomaterials
US6174326B1 (en) 1996-09-25 2001-01-16 Terumo Kabushiki Kaisha Radiopaque, antithrombogenic stent and method for its production

Also Published As

Publication number Publication date
US6461665B1 (en) 2002-10-08
ES2203177T3 (es) 2004-04-01
EP1112097B1 (en) 2003-06-25
AU5765299A (en) 2000-03-27
DE69909104T2 (de) 2004-04-08
CA2342991A1 (en) 2000-03-16
EP1112097A1 (en) 2001-07-04
ATE243538T1 (de) 2003-07-15
DE69909104D1 (de) 2003-07-31
JP4152075B2 (ja) 2008-09-17
BR9913516B1 (pt) 2010-09-21
NO984143D0 (no) 1998-09-09
CA2342991C (en) 2009-01-27
KR100669132B1 (ko) 2007-01-17
JP2003507082A (ja) 2003-02-25
KR20010088799A (ko) 2001-09-28
AU757913B2 (en) 2003-03-13
PT1112097E (pt) 2003-11-28
WO2000013718A1 (en) 2000-03-16
BR9913516A (pt) 2001-06-05
DK1112097T3 (da) 2003-10-20

Similar Documents

Publication Publication Date Title
NO984143L (no) Ny prosess for å fremstille overflatemodifiserende stoffer
NO872602D0 (no) Elektrisk kontaktsett, saerlig for bruk under vann.
ES536909A0 (es) Procedimiento para la preparacion de compuestos complejos de piroxicam con ciclodestrinas
DE68902916D1 (de) Herstellung von quecksilberfreiem synthesegas, reduktionsgas oder brenngas.
DE69704433D1 (de) Herstellung von kohlenwasserstofflöslichen hydrocarbylaluminoxanen
DE69525639D1 (de) Herstellung kleiner partikel
EA200000473A1 (ru) Состав модифицированного крахмала для удаления частиц из водных дисперсий
ID26310A (id) Produksi kontinyu 1,3-dioksolan-2-ona
BR9916627B1 (pt) processo para produzir transglutaminase tendo atividade enzimática.
AU2842199A (en) Ophthalmic composition comprising a beta-blocker
DE59709869D1 (de) Neue substanzbibliothek und damit hergestellte supramolekulare komplexe
EA199800152A1 (ru) Лечение синдрома дефицита внимания/гиперактивности
FI963749A (fi) Huokoinen metallikomposiittikappale
DE60002103D1 (de) Stabilisierung von blutplättchen
NO20012854L (no) Fremgangsmåte for avvanning av organiske v¶sker
ATE246254T1 (de) Verwendung von oxidationsfördernden chemikalien für die oxidation von einem polymer, das die alkoholkonfiguration eines oxidierbaren galaktosetyps enthält.
NO20003151L (no) Kationisk tverrbundet stivelse med stabil og "skreddersydd" viskositet
ES509901A0 (es) "digestor para la fermentacion celulosica, para la produccion de metano por fermentacion anaerobia".
DE69421195D1 (de) Einstufige herstellung von 4,6 dinitroresorcinol aus resorcinol
DE3886225D1 (de) Pyruvat-Oxidase, ihre Herstellung und Verwendung.
IT1216721B (it) Procedimento per la produzione di bricchette di combustibile senza fumo trattate.
ATE309371T1 (de) Protein mit dnase-aktivität
HUP9900959A2 (hu) Eljárás 3-metoxi-1-propanol előállítására
DE69729114D1 (de) 1,3-diphenylphosphinopropan-liganden und entsprechende übergangsmetallkomplexe, deren herstellung und verwendung
SE9600285D0 (sv) Modification of starch

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application